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Although rare, atrial myxoma is the most common primary tumour of the heart. Its relation to immunosuppression in
solid organ transplant is presently debateable. We report the case of a 71-year-old male patient who underwent renal
transplant 17 years prior. Since that time he continued high dose immunosuppression without physician consultation
and presented to us with atrial myxoma and its complications raising the question of any association between
immunosuppression and the development of atrial myxoma.
 2012 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.
Abbereviatons: BD, bis in die (twice daily), OD, omne in die (once a day), MCA, middle cerebral artery, CT scan,
computerized tomography, mg, milligramKeywords: Atrial myxoma, Immunosuppression, Solid organ transplantCase report
We present a case of a 71-year-old male, whounderwent a renal transplant in 1995 for
severe nephropathy, after which he was started
on immunosuppression with 100 mg of cyclospor-
ine twice daily (BD), 50 mg Azathioprim once daily
(OD) and 5 mg Prednisolone OD. A complete
evaluation was performed before the surgery as
a routine preanaesthetic workup yielding no
abnormality except severe nephropathy. Seven-
teen years later he presented to us as massive
right middle cerebral artery (Rt. MCA) infarct.
History revealed complaints of recurrent ischemic
attacks, weakness and dyspnoea on exertion with1016–7315  2012 King Saud University.
Production and hosting by Elsevier B.V. All rights reserved.
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http://dx.doi.org/10.1016/j.jsha.2012.07.002palpitation for one year prior with insignificant
past medical history except renal transplant
(normal functioning graft) seventeen years prior.
On physical examination vitals were all normal
with left hemi paresis, slurring of speech and cra-
nial nerve palsy. Lab investigations were all nor-
mal except mildly elevated serum creatinine to
2 mg/dl. CT scan showed Rt. MCA infarct. Initial
investigation didn’t reveal any other abnormality.
Later echocardiography was done which revealed
the presence of mass in left atrium measuring
3.58 cm  1.95 cm (Fig. 1). The mass had a multi-
lobular appearance and was very mobile, sugges-
tion potential embolism. The patient was planned
for cardiac surgery after optimisation but theProduction and hosting by Elsevier
Figure 1. Transthoracic echocardiography view showing atrial mass.
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aged conservatively. His neurological status
recovered fully and was discharged to home upon
request. Further follow up with the patient re-
vealed stable medical history until the time of this
manuscript submission.Discussion
Primary tumors of the heart are rare. Approxi-
mately three-quarters are histologically benign,
and the majority of these tumors are myxomas
[1]. We report a case of atrial myxoma which
evolved over a long period of immunosuppres-
sion. We were unable to determine exactly when
the tumour began developing but the patient be-
came symptomatic one year prior to presenting.
The most frequent type of tumors in chronic
immunosuppression are lymphoproliferative dis-
orders and squamous cell carcinoma [2], however
there is no established correlation with atrial
myxoma.
Very few cases of similar associations have been
reported in the literature. A 65-year-old patient
was reported to have developed cardiac myxoma
in the left atrium following heart transplant. Immu-
nosuppression consisted of cyclosporine, azathip-
rine and Prednisolone [3]. In a second case, a 51-
year-old man developed myxoma following a heart
transplant for ischemic cardiomyopathy and the
immunosuppressive regimen included cyclospor-
ine, azathiprine and Prednisolone [4]. A third case
reported in literature was a 17-year-old thalasse-
mic who underwent allogenic bone marrow trans-plant, who developed atrial myxoma with 47 days
of starting the immunosuppression with cyclo-
sporin [5]. Finally, a fourth case reported is of a
30-year-old diabetic female who underwent renal
and pancreatic transplant and developed atrial
myxoma after being on immunosuppression with
cyclosporine, micophenolate mofetil and Predniso-
lone [6]. All these cases including the index case
were immunosuppressed with cyclosporin, which
raised the suspicion of specific association of cyclo-
sporin medication with the development of atrial
myxoma, however, this is difficult to assess due to
rarity of the cardiac myxoma.
The association between neoplasm and
immunosuppressive therapy is mediated through
several pathogenic factors. Indirectly, immuno-
suppressive drugs greatly increase the post-
transplant risk of malignancy by impairing cancer
surveillance and facilitating the action of onco-
genic viruses [7]. However, the direct pro- and
anti-oncogenic actions of immunosuppressants
also play an important role. Further a cell culture
study demonstrated the inhibitory effect of
cyclosporin on cytokine production including the
IL-6 and IL-8 (cytokines know to have effect on
the development of tumors) by the cardiac myx-
oma cells [8]. Our index case further strengthens
the association of immunosuppression with the
development of atrial myxoma.Conflict of interest
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